73 /100
HIGH RISK
Score updated May 21, 2026

NUWE — Nuwellis, Inc. Dilution Risk Tracker

Track NUWE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NUWE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
95
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
53%
💰 Capital Raise 75%
• Critical: only 1.9 months cash remaining
• Active shelf registration ($28M, 1074% of market cap)
🔄 Reverse Split 45%
• 50-day avg $1.11 approaching $1 threshold
• Only 2 months cash — financial pressure
📉 Score Deterioration 10%
• Score in HIGH risk zone (73/100)
🔔 Track NUWE — Get forecast alerts →

💹 Market Data

Market Cap$2.61M
Shares Outstanding2.64M
Float2.61M
Cash$2.08M
Debt$265.0K
Short InterestN/A

🏛 Institutional Holdings

11.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track NUWE for full holder detail →

📉 Short Interest

Short Interest70.2K
Days to Cover1.9
% of Float2.7%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
4 INSIDER TRANSACTION Apr 29, 2026
4 INSIDER TRANSACTION Apr 29, 2026
4 INSIDER TRANSACTION Apr 29, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track NUWE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NUWE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ALLR APLD ASMB ASPI BACC
🔬 More Research for NUWE
📊 NUWE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NUWE Signal Convergence & Dark Pool Activity — StonkWhisper 📄 NUWE Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.